Evolving trade policies and tariffs strain bio/pharmaceutical manufacturers, affecting profits and operational strategies.

The changes, required for safety labeling of all opioid drugs, will emphasize the risks with long-term use to combat misuse ...

EMA encourages NAMs to replace animal testing, aligning with 3Rs principles, and has published a concept paper on regulatory ...

FDA’s latest whitepaper shows how scalable quality management investments in pharma reduce costs, improve reliability, and ...

The two companies have entered into an agreement to develop respiratory, immunology, inflammation, and cancer therapies.

In this podcast episode, we discuss sustainable approaches to such equipment and materials as medical propellants, flow ...

If action is not taken within 60 days, the White House said it would “deploy every tool in our arsenal” to improve drug pricing practices for American patients.

Re-Vana’s drug delivery technology is designed to release treatments over a 6- to 12-month period, with the goal of reducing ...

The agency has given a positive recommendation for a change in the gas propellant in Trixeo Aerosphere and Riltrava ...

While a one-stop shop still has its advantages, sponsor companies and CDMOs are starting to see each other not as ...

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and expert industry news.

The company will build a multi-billion-dollar drug manufacturing center in Virginia that will focus on chronic diseases, as ...